Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center
ID: 360441Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360441
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for a Cooperative Agreement to establish a Research Coordinating Center (RCC) focused on optimal treatment strategies for the use of anti-obesity medications (AOMs) in children and adolescents. The RCC will coordinate a consortium of clinical centers to evaluate various AOM treatment strategies, including the timing of AOM initiation, weight loss rates, medication classes, dosages, and the integration of lifestyle therapies to support healthy development and minimize long-term reliance on AOMs. This initiative is critical for addressing obesity in youth and ensuring effective treatment protocols, with one award expected to be made. Interested applicants can reach out to Dr. Stavroula K. Osganian at (301) 827-6939 or via email at voula.osganian@nih.gov for further details. The estimated project start date is July 1, 2027, with applications due by December 1, 2026.

    Point(s) of Contact
    Stavroula K. Osganian, MD, ScD, MPH
    (301) 827-6939
    voula.osganian@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for a cooperative agreement aimed at developing optimal treatment strategies for the use of anti-obesity medications (AOMs) in children and adolescents. This initiative seeks clinical centers to join a consortium focused on testing AOM treatment strategies that maximize benefits while minimizing risks, emphasizing healthy growth, nutritional intake, and mental well-being. The project is critical in addressing obesity in youth, with a focus on determining the best developmental stages for AOM initiation and evaluating predictors of treatment response. Interested applicants can reach out to Dr. Stavroula K. Osganian at (301) 827-6939 or via email at voula.osganian@nih.gov. The estimated award date is July 1, 2027, with applications due by December 1, 2026, and a total of three awards expected.
    Renewal of NIA Research Centers Collaborative Network (RCCN)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the renewal of the Research Centers Collaborative Network (RCCN), aimed at enhancing collaborations across its seven research centers focused on aging research. This initiative seeks to leverage NIH's significant investments by fostering interdisciplinary efforts and sustaining high-value activities, while also encouraging new initiatives such as pilot funding programs and enhanced mentoring infrastructure. Interested applicants, particularly those with expertise in aging research, are advised to prepare for this opportunity, with the estimated synopsis posting date on March 1, 2026, and a closing date for applications anticipated by May 25, 2026. For further inquiries, potential applicants can contact Amelia Karraker at amelia.karraker@nih.gov or by phone at 301-496-3131.
    Nutrition Obesity Research Centers (NORCs)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Nutrition Obesity Research Centers (NORCs) program, which aims to establish core centers that contribute to an integrated program of nutrition and obesity research. This funding opportunity supports three primary research-related activities: Research Core services, a Pilot and Feasibility program, and an Enrichment program, all designed to enhance the efficiency and multidisciplinary nature of research in this critical health area. With an estimated total program funding of $3.6 million and the expectation of awarding three grants, interested applicants can reach out to Dr. Mary Evans at evansmary@niddk.nih.gov or call 301-594-4578 for further information. The application process is open until October 1, 2026, with awards anticipated to be made by June 1, 2027.
    Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting the renewal of a funding opportunity announcement for the Multiple Chronic Disease Research Centers Coordinating Center (MCD-RCC), which will be funded through a cooperative agreement. This initiative aims to support comprehensive research centers focused on the prevention, diagnosis, treatment, and management of co-existing chronic diseases, with an emphasis on reducing health disparities as mandated by Public Law 116-260. The MCD-RCC will facilitate collaboration, data management, and community engagement, serving as a national resource to enhance research efforts in this critical area. The estimated total program funding is $20 million, with one award expected, and interested applicants are encouraged to prepare for the application process, which is anticipated to open in late 2025. For further inquiries, potential applicants can contact Dr. Anuradha Patel at Anuradha.patel@nih.gov or by phone at 301-594-1197.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated, high-risk multi-center clinical trials through the Notice of Funding Opportunity (NOFO) PA-25-147. This cooperative agreement (U01) aims to support innovative studies that address critical health issues related to diabetes, digestive diseases, and kidney conditions, requiring proposals to be hypothesis-driven and operationally classified as high-risk. The program emphasizes the importance of diverse perspectives in research and mandates that planning activities be completed prior to application submission. Interested applicants should note that the application period opens on January 3, 2025, with a submission deadline of November 5, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of a Clinical Coordinating Center (CCC) to support multi-site investigator-initiated clinical trials focused on natural products, such as botanicals and dietary supplements. Applicants are required to submit a comprehensive plan detailing project management, participant recruitment, and clinical trial execution, while also ensuring alignment with NIH standards. This initiative emphasizes the importance of evidence-based research in natural products and mandates the submission of a corresponding Data Coordinating Center (DCC) proposal to oversee data management and analysis. Interested applicants should note that the application deadline is July 15, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For additional details, applicants can refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-24-123.html.
    Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Complementary and Integrative Health (NCCIH), is inviting applications for a Data Coordinating Center (DCC) to support multi-site, investigator-initiated clinical trials focused on mind and body interventions. The DCC will be responsible for project coordination, administrative support, data management, and biostatistical analysis for Phase III clinical trials, and must be submitted alongside a Clinical Coordinating Center (CCC) proposal. This initiative is crucial for advancing research in complementary and integrative health strategies that address public health challenges, emphasizing participant diversity and data integrity. Interested applicants should note that the application deadline is January 20, 2025, with a funding period of up to 7 years, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting high-risk, multi-center observational studies related to diabetes, digestive, kidney, and associated diseases. This funding opportunity emphasizes hypothesis-driven research that engages diverse populations, particularly underserved communities, and requires a comprehensive study design, community engagement, and a detailed budget. The initiative is crucial for advancing health equity and enhancing participant diversity in clinical research. Interested applicants should note that the submission period opens on January 3, 2025, with a closing date of November 5, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking a qualified entity to continue the Physiology of the Weight Reduced State (POWERS) Study through a cooperative agreement. This initiative aims to further investigate the physiological processes that contribute to individual differences in weight regain after weight loss, allowing for the completion of the clinical trial and subsequent data analysis. The POWERS study is critical for understanding obesity and developing effective weight management strategies. Interested applicants should note that the estimated project start date is April 1, 2027, with a single award anticipated, and they can contact Dr. Mary Evans at NIDDKObesity@nih.gov or by phone at 301-594-4578 for further information.
    Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Natural Product Multi-Site Clinical Trial Data Coordinating Center (DCC) through a cooperative agreement mechanism. This initiative invites applications for a DCC that will collaborate with a Clinical Coordinating Center (CCC) to conduct multi-site clinical trials focused on the efficacy and effectiveness of natural products, requiring simultaneous submission of both applications. The program emphasizes the importance of maintaining data integrity, promoting diversity in participant recruitment, and achieving specific milestones for continued funding, while also necessitating a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in research. Interested applicants can find more information and application details on the NIH grants website, with a submission deadline of July 14, 2026, and a contact email for inquiries at grantsinfo@nih.gov.